Small molecule probes to target the human Mediator complex.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 25705053)

Published in Isr J Chem on August 01, 2013

Authors

Andrew J Phillips1, Dylan J Taatjes2

Author Affiliations

1: Dept. of Chemistry, Yale University, New Haven, CT 06520 USA.
2: Dept. of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80303 USA.

Articles citing this

The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol (2015) 1.97

The Mediator complex and transcription regulation. Crit Rev Biochem Mol Biol (2013) 1.64

Articles cited by this

Hallmarks of cancer: the next generation. Cell (2011) 140.01

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42

Dissecting the regulatory circuitry of a eukaryotic genome. Cell (1998) 23.62

The druggable genome. Nat Rev Drug Discov (2002) 13.61

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res (2008) 9.65

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12

A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell (1994) 8.44

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science (2004) 7.63

Transcription factors as targets for cancer therapy. Nat Rev Cancer (2002) 7.27

MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (1988) 6.78

Target-oriented and diversity-oriented organic synthesis in drug discovery. Science (2000) 5.72

Human disease genes. Nature (2001) 5.31

Direct inhibition of the NOTCH transcription factor complex. Nature (2009) 4.82

The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet (2010) 4.46

Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature (1999) 4.40

Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit. Nature (1988) 3.93

Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 3.61

Structure, function, and activator-induced conformations of the CRSP coactivator. Science (2002) 3.52

Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell (1999) 3.47

Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature (2002) 3.42

The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci (2010) 3.38

CBP and p300: HATs for different occasions. Biochem Pharmacol (2004) 3.38

Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature (1999) 3.32

Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature (1999) 3.24

An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature (2006) 3.23

Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci U S A (1998) 3.18

Transcriptional regulation and its misregulation in disease. Cell (2013) 2.92

Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide. J Am Chem Soc (2007) 2.71

A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell (2006) 2.69

The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature (1999) 2.61

Association of an activator with an RNA polymerase II holoenzyme. Genes Dev (1995) 2.61

Function and regulation of the Mediator complex. Curr Opin Genet Dev (2011) 2.51

Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell (1989) 2.40

Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action. Mol Cell (2000) 2.39

Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature (2002) 2.34

Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science (2002) 2.33

Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL. J Med Chem (2007) 2.09

Mediator as a general transcription factor. J Biol Chem (2005) 1.88

Fragment-based approaches in drug discovery and chemical biology. Biochemistry (2012) 1.78

A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol (2010) 1.75

Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis. J Am Chem Soc (2003) 1.69

Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions. Proc Natl Acad Sci U S A (2003) 1.54

Activator-Mediator binding regulates Mediator-cofactor interactions. Proc Natl Acad Sci U S A (2010) 1.54

Interactions between subunits of the Mediator complex with gene-specific transcription factors. Semin Cell Dev Biol (2011) 1.50

TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA. Genes Dev (2002) 1.45

Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor. Angew Chem Int Ed Engl (2007) 1.38

The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J (2002) 1.38

Diversity-oriented synthesis; a spectrum of approaches and results. Org Biomol Chem (2008) 1.37

Design and synthesis of alpha-helical peptides and mimetics. Org Biomol Chem (2007) 1.35

p53 activates transcription by directing structural shifts in Mediator. Nat Struct Mol Biol (2010) 1.33

Structure of the stapled p53 peptide bound to Mdm2. J Am Chem Soc (2011) 1.30

Architecture of the Mediator head module. Nature (2011) 1.30

Complexity in transcription control at the activation domain-mediator interface. Sci Signal (2009) 1.29

Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc Natl Acad Sci U S A (2003) 1.28

The Mediator complex and transcription elongation. Biochim Biophys Acta (2012) 1.24

beta-Peptides as inhibitors of protein-protein interactions. Bioorg Med Chem (2005) 1.24

Structure of the mediator head module bound to the carboxy-terminal domain of RNA polymerase II. Proc Natl Acad Sci U S A (2012) 1.23

Design and structure of stapled peptides binding to estrogen receptors. J Am Chem Soc (2011) 1.22

Molecular architecture of the human Mediator-RNA polymerase II-TFIIF assembly. PLoS Biol (2011) 1.22

Structure and function of CRSP/Med2; a promoter-selective transcriptional coactivator complex. Mol Cell (2004) 1.21

Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. Future Med Chem (2009) 1.18

Structure of the Mediator head module. Nature (2012) 1.17

Structure of the VP16 transactivator target in the Mediator. Nat Struct Mol Biol (2011) 1.17

Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors. ACS Chem Biol (2009) 1.16

A structural perspective on Mediator function. Curr Opin Cell Biol (2012) 1.13

Mechanism of Mediator recruitment by tandem Gcn4 activation domains and three Gal11 activator-binding domains. Mol Cell Biol (2010) 1.12

Mediator and human disease. Semin Cell Dev Biol (2011) 1.10

Small molecule transcription factor mimic. J Am Chem Soc (2004) 1.10

Using a fragment-based approach to target protein-protein interactions. Chembiochem (2013) 1.09

Structure and VP16 binding of the Mediator Med25 activator interaction domain. Nat Struct Mol Biol (2011) 1.08

Transcription factors in disease. Curr Opin Genet Dev (1996) 1.04

The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex. Mol Cell (2011) 1.02

A small molecule transcriptional activation domain. J Am Chem Soc (2004) 1.01

Activator Gcn4 employs multiple segments of Med15/Gal11, including the KIX domain, to recruit mediator to target genes in vivo. J Biol Chem (2009) 1.00

Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry. Curr Protein Pept Sci (2008) 0.98

Using peptides to study protein-protein interactions. Future Med Chem (2010) 0.96

Mediator and SAGA have distinct roles in Pol II preinitiation complex assembly and function. Cell Rep (2012) 0.91

A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction. J Am Chem Soc (2003) 0.88

Transient-state kinetic analysis of transcriptional activator·DNA complexes interacting with a key coactivator. J Biol Chem (2011) 0.88

Mediator and post-recruitment regulation of RNA polymerase II. Transcription (2012) 0.87

Stereochemical promiscuity in artificial transcriptional activators. J Am Chem Soc (2005) 0.87

Targeting the transcriptional machinery with unique artificial transcriptional activators. J Am Chem Soc (2003) 0.87

Unraveling framework of the ancestral Mediator complex in human diseases. Biochimie (2011) 0.87

Stabilized helical peptides: overview of the technologies and therapeutic promises. Expert Opin Drug Discov (2011) 0.87

Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics. Biopolymers (2011) 0.82

Wrenchnolol derivative optimized for gene activation in cells. J Am Chem Soc (2009) 0.80

Assessing the permissiveness of transcriptional activator binding sites. Biopolymers (2008) 0.78